Stopping antithrombotic therapy may be the most modifiable mechanism behind adverse cardiovascular outcomes after gastrointestinal bleeding.
A trial directly comparing Eliquis and Xarelto - two commonly used blood-thinning drugs from ​the same class of medicines - found that Eliquis carries a clearly lower risk of dangerous bleeding in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results